Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of the American College of Cardiology

• Publication date

  2002-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0735-1097(02)01726-6PMID 11923039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium.

  2001influential reference
• Current medical therapy for advanced heart failure (Reprinted from Am Heart, vol 135, pg S231-S248, 1998)

  2000cited by this paper
• Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial.

  2000cited by this paper
• Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy.

  2000cited by this paper
• Current medical therapy for advanced heart failure.

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• Noninvasive assessment of myocardial viability.

  2000cited by this paper
• Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.

  1999cited by this paper
• Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome.

  1999cited by this paper
• Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy.

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.

  1999cited by this paper
• Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction.

  1999cited by this paper
• Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.

  1999cited by this paper
• Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction.

  1999cited by this paper
• Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure

  1998cited by this paper
• Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients.

  1998cited by this paper
• Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome.

  1998cited by this paper
• Current medical therapy for advanced heart failure.

  1998cited by this paper
• Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.

  1998cited by this paper
• Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions.

  1998cited by this paper
• Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction.

  1998cited by this paper
• Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.

  1998cited by this paper
• Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction.

  1998cited by this paper
• Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging

  1997cited by this paper
• Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data.

  1997cited by this paper
• Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction.

  1997cited by this paper
• Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability.

  1997cited by this paper
• Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.

  1997cited by this paper
• Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.

  1997cited by this paper
• Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction

  1996cited by this paper
• Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.

  1996cited by this paper
• Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.

  1995cited by this paper
• Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy.

  1995cited by this paper
• Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.

  1994cited by this paper
• Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization.

  1994cited by this paper
• Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.

  1994cited by this paper
• Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.

  1994cited by this paper
• Prognosis of Patients With Left Ventricular Dysfunction, With and Without Viable Myocardium After Myocardial Infarction: Relative Efficacy of Medical Therapy and Revascularization

  1994cited by this paper
• Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging.

  1993cited by this paper
• Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3-year mortality with and without revascularization.

  1993cited by this paper
• Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.

  1992cited by this paper
• Surgical survival benefits for coronary disease patients with left ventricular dysfunction.

  1988cited by this paper
• Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: a Coronary Artery Surgery Study Registry Study.

  1988cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium".

  1986cited by this paper
• Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry.

  1985cited by this paper
• Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS).

  1983cited by this paper
• Coronary bypass surgery for chronic angina--1981. A perspective.

  1982cited by this paper

• Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

  2026cites this paper
• Optimizing Revascularization in Ischemic Cardiomyopathy: Comparative Evidence on the Benefits and Indications of CABG and PCI

  2025cites this paper
• Predictive Value of Dobutamine Stress Echocardiography–Derived Myocardial Viability in Patients with Ischemic Cardiomyopathy

  2025cites this paper
• Viability and Congestive Heart Failure.

  2025cites this paper
• The Role of Imaging Modalities in Estimating Myocardial Viability: A Narrative Review

  2025cites this paper
• The Role of Myocardial Revascularization in Ischemic Heart Failure in the Era of Modern Optimal Medical Therapy

  2025cites this paper
• Myocardial Viability: Evolving Insights and Challenges in Revascularization and Functional Recovery

  2025influential citation
• Advanced Computed Tomography and Magnetic Resonance Imaging in Ischemic and Nonischemic Cardiomyopathies

  2025cites this paper
• Imágenes en insuficiencia cardíaca

  2025cites this paper
• Triglyceride-glucose index as a novel predictor of major adverse cardiovascular events in patients with coronary revascularization: a meta-analysis of cohort studies

  2025cites this paper
• Case Report on Rescue Coronary Artery Bypass Grafting on An Arrest Survival Patient with Heart Failure with Mildly Reduced Ejection Fraction

  2025cites this paper
• Cardiac Positron emission tomography/ computed tomography (PET/CT) in current cardiology guidelines.

  2025cites this paper
• Functional Flow Reserve (FFR) as a Surrogate Marker of Myocardial Viability: A Case Demonstration Highlighting the Forgotten Utility

  2025cites this paper
• Impact of baseline risk of death or hospitalization on effectiveness of revascularization in patients with ischaemic left ventricular dysfunction—a prespecified analysis of REVIVED-BCIS2

  2025cites this paper
• Current Concepts in Revascularization for Ischemic Heart Disease With Reduced Ejection Fraction.

  2025cites this paper
• Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease and Left Ventricular Dysfunction

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Radionuclide imaging techniques for assessing myocardial viability: Clinical applications, evidence, and future directions.

  2025cites this paper
• Evaluation of Coronary Artery Disease and Ischemia by Echocardiography: Advances in Technology and Techniques.

  2025cites this paper
• Ischemic Cardiomyopathy: A Bedside Case Discussion for Residents

  2025cites this paper
• Case Report: PET-CT ischemia and viability maps guiding an emergency revascularization

  2025cites this paper
• Management of Ischemic Heart Disease in Patients With Heart Failure: JACC: Heart Failure Position Statement.

  2025cites this paper
• Angioplastie des occlusions totales chroniques : Rapport de cinq ans d’expérience dans un centre Tunisien multi-opérateurs

  2025cites this paper
• Advanced Cardiac Imaging in Treatment Decision-Making for Severe Left Ventricular Dysfunction: A Systematic Review and MetaAnalysis

  2025cites this paper
• Cardiac Imaging in the Diagnosis and Management of Heart Failure

  2025cites this paper
• When a meta-analysis can be really useful?

  2025cites this paper
• Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease.

  2025cites this paper
• 18F-Fluorodeoxyglucose Imaging for Assessing Cardiovascular Inflammation

  2025cites this paper
• JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure.

  2025cites this paper
• Contemporary management of ischemic cardiomyopathy: The synergy of medical, revascularization, and device therapies.

  2025cites this paper
• Guideline for Chronic Coronary Syndrome - 2025.

  2025cites this paper
• Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock Substudy.

  2025cites this paper
• Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.

  2024cites this paper
• Impact of CT attenuation correction on viable myocardium detection in combined SPECT and PET/CT: A retrospective cohort study

  2024cites this paper
• Determination of viable myocardium through delayed enhancement cardiac magnetic resonance imaging combined with 18F-FDG PET myocardial perfusion/metabolic imaging before CABG

  2024cites this paper
• Evaluation of Clinical Variables Affecting Myocardial Glucose Uptake in Cardiac FDG PET

  2024cites this paper
• Simultaneous Viability Assessment and Invasive Coronary Angiography Using a Therapeutic CT System in Chronic Myocardial Infarction Patients.

  2024cites this paper
• Outcomes of Percutaneous Revascularization in Severe Ischemic Left Ventricular Dysfunction

  2024cites this paper
• Outcomes of Coronary Artery Bypass Grafting in Patients With Impaired Left Ventricular Function and the Role of Preoperative Myocardial Viability

  2024cites this paper
• 2024 ESC Guidelines for the management of chronic coronary syndromes.

  2024cites this paper
• Clinical impact of multimodality assessment of myocardial viability

  2024cites this paper
• Review of Myocardial Ischemia, Scar, and Viability Estimation with Molecular Magnetic Resonance Imaging

  2024cites this paper
• The Current State of Coronary Revascularization: Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Interventions

  2024cites this paper
• Conditions for late gadolinium enhancement MRI in myocardial infarction model rats that better reflect microscopic tissue staining

  2024cites this paper
• Current indications and surgical strategies for myocardial revascularization in patients with left ventricular dysfunction: a scoping review

  2024cites this paper
• Controversias en la revascularización y el estudio de viabilidad miocárdica en el síndrome coronario crónico

  2024cites this paper
• REVIVED BCIS-2: update and key learnings

  2024cites this paper
• Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo

  2024cites this paper
• Development of a Novel Nomogram to Predict Major Adverse Cardiac Events in Patients with Chronic Total Occlusion

  2024cites this paper
• Coronary Revascularisation in Heart Failure with Reduced Ejection Fraction

  2024cites this paper
• Myocardial viability on trial

  2024cites this paper
• O que o Cardiologista Espera da Avaliação de Viabilidade Miocárdica

  2024cites this paper
• Efficacy of revascularization in CTO patients based on hibernating myocardium therapy

  2024cites this paper
• Molecular Imaging of Heart Failure: An Update and Future Trends.

  2024cites this paper
• Investigation Myocardial Perfusion Scan Parameters and Walls Motion in Patients undergoing Cardiac Surgery

  2024cites this paper
• Selecting the appropriate patients for coronary artery bypass grafting in ischemic cardiomyopathy—importance of myocardial viability

  2024cites this paper
• Viabilité myocardique

  2024cites this paper
• Global, segmental, and layer-specific two-dimensional speckle tracking echocardiography immediately after acute myocardial infarction as a predictive tool to assess myocardial viability and scar size

  2024cites this paper
• The efficacy of revascularization in ischemic cardiomyopathy.

  2024cites this paper
• A Narrative Review of Revascularization in Chronic Coronary Syndrome/Disease: Concepts and Misconceptions

  2024cites this paper
• What do Cardiologists Expect Towards Myocardial Viability Assessment

  2024cites this paper
• In search of the answers to the viability questions.

  2024cites this paper
• Imaging of Cardiac Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis.

  2023cites this paper
• Myocardial Perfusion Scan Study before and after On-Pump Coronary Artery Bypass Grafting Surgery – A Single-Center Study

  2023cites this paper
• The Utility of Low-Dose-Dobutamine Stress Echocardiography in Patients with Heart Failure with Reduced Ejection Fraction: An Update

  2023cites this paper
• Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy

  2023cites this paper
• The Evolving Paradigm of Revascularization in Ischemic Cardiomyopathy: from Recovery of Systolic Function to Protection Against Future Ischemic Events

  2023cites this paper
• Commentary: The Power of a Patch: Utilizing Exosome Therapy to Treat Heart Disease.

  2023cites this paper
• Revascularisation for Ischaemic Cardiomyopathy

  2023cites this paper
• Role of cardiac imaging in management of heart failure

  2023cites this paper
• Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis.

  2023cites this paper
• Hybrid PET/MR in Cardiac Imaging.

  2023cites this paper
• Current Role of Myocardial Viability Imaging Using Positron Emission Tomography in Patients with Chronic Ischemic Heart Failure and Left Ventricular Dysfunction

  2023cites this paper
• What is the role of coronary revascularization to recover the contractility of the dysfunctional heart?

  2023cites this paper
• Phenotyping heart failure by nuclear imaging of myocardial perfusion, metabolism, and molecular targets

  2023cites this paper
• Tools for Timing in Heart Failure; what - when - how?

  2023cites this paper
• The impact of viability assessment using cardiac MRI and echocardiogram on the outcome of revascularization in patients with multi-vessels coronary artery disease and moderate to severe ischemic cardiomyopathy

  2023cites this paper
• Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How

  2023cites this paper
• Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

  2023cites this paper
• Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction

  2023cites this paper
• The Role of Positron Emission Tomography in Advancing the Understanding of the Pathogenesis of Heart and Vascular Diseases

  2023cites this paper
• 2023 National Heart Center/Saudi Heart Association Focused Update of the 2019 Saudi Heart Association Guidelines for the Management of Heart Failure

  2023cites this paper
• Clinical Application of Myocardial Perfusion SPECT in Patients with Suspected or Known Coronary Artery Disease. What Role in the Multimodality Imaging Era?

  2023cites this paper
• In-Hospital Outcomes Following Surgical Revascularization of Chronic Total Coronary Occlusions

  2023cites this paper
• Current status and perspectives of nuclear cardiology

  2023cites this paper
• A review of the conservative versus invasive management of ischemic heart failure with reduced ejection fraction.

  2023cites this paper
• Medical Decision-Making and Revascularization in Ischemic Cardiomyopathy.

  2023cites this paper
• Myocardial Scar and Revascularization on Mortality in Ischemic Cardiomyopathy (from the Late Gadolinium Enhancement Cardiac Magnetic Resonance Study).

  2023cites this paper
• Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Coronary revascularization in patients with left ventricle systolic dysfunction, current challenges and clinical outcomes.

  2022cites this paper
• Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy

  2022cites this paper
• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  2022cites this paper
• Dobutamine stress echocardiography combined with two-dimensional speckle tracking echocardiography in late presenters of STEMI patients in a tertiary care hospital in eastern India

  2022cites this paper
• Myocardial Viability Testing in the Management of Ischemic Heart Failure

  2022cites this paper
• Speckle-tracking echocardiography for predicting improvement of myocardial contractile function after revascularization: a meta-analysis of prospective trials

  2022cites this paper
• Long-Term Prognostic Value of Myocardial Viability by Myocardial Contrast Echocardiography in Patients after Acute Myocardial Infarction: A Systematic Review and Meta-Analysis

  2022cites this paper
• Patient Selection and Clinical Indication for Chronic Total Occlusion Revascularization—A Workflow Focusing on Non-Invasive Cardiac Imaging

  2022cites this paper
• Multimorbidity and combined interventions for patients with coronary heart disease in Chinese population: Latent class analysis of a multi-center study.

  2022cites this paper
• Lack of Viability Should Not Deny Surgical Revascularisation to Patients With Poor Left Ventricular Function.

  2022cites this paper